Cardiac resynchronization therapy: Gender related differences in left ventricular reverse remodeling

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 11, 2007, Pages 1349-1355

  Lilli, Alessio ^a   Ricciardi, Giuseppe ^a   Porciani, Maria Cristina ^a   Perini, Alessandro Paoletti ^a   Pieragnoli, Paolo ^a   Musilli, Nicola ^a   Colella, Andrea ^a   Pace, Stefano Del ^a   Michelucci, Antonio ^a   Turreni, Federico ^b   Sassara, Massimo ^b   Achilli, Augusto ^b   Serge Barold, S ^c   Padeletti, Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Cardiac resynchronisation; Heart failure; Reverse remodeling; Women

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL PARAMETERS; MULTIPLE REGRESSION; POPULATION; SEX DIFFERENCE;

AGE DISTRIBUTION; AGED; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 35748961671     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00870.x     Document Type: Article

References (40)

1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas, Tex: American Heart Association 2005.
2. Jessup M, Pina IL. Is it important to examine gender differences in the epidemiology and outcome of the severe heart failure? J Thor Cardiovasc Surg 2004 127: 1247 1252.
3. Opasich C, De Feo S, Ambrosio GA, Bellis P, Di Learda A, Di Tano G, Fico D, et al. The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologist and internists. Eur J Heart Fail 2004 6: 769 779.
4. Sheppard R, Behlouli H, Richard H, Pilote L. Effect of gender on treatment, resource, utilization, and outcomes in congestive heart failure in Quebec, Canada. Am J Cardiol 2005 95: 955 959.
5. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993 22: 6A 13A.
6. Adams KF, Dunlap SH, Sueta CA, Patterson JH, Blauwet MB, Jensen LR, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996 28: 1781 1788.
7. Stromberg A, Martensson J. Gender differences in patients with heart failure. Eur J Cardiovas Nur 2003 2: 7 18.
8. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, et al. Gender differences in advanced heart failure: Insights from the best study. J Am Coll Cardiol 2003 42: 2128 2134.
9. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P on Behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure results from the cardiac insufficiency bisoprolol study (CIBIS II). Circulation 2001 103: 375 380.
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).
11. McAlister FA, Ezekowitz JA, Wiebe N, Rowe MB, Spooner C, Crumley E, Hartling L, et al. Systematic Review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004 141: 381 390.
12. Kass DA. Cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2005 16: S35 S41.
13. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L for the Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352: 1539 1549.
14. Yu CM, Bleeker GB, Fung JWH, Schalij MJ, Zhang Q, van der Wall EE, Chan YS, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005 112: 1580 1586.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 18: 1440 1463.
16. Porciani MC, Dondina C, Macioce R, Demarchi G, Pieragnoli P, Musilli N, Colella A, et al. Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol 2005 95: 1108 1110.
17. Kindermann M, Frolhig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: Mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol 1997 20: 2453 2462.
18. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Multicenter automatic defibrillator implantation trial ii investigators, prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346: 877 883.
19. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic. JAMA 2003 289: 194 202.
20. Hedberg P, Lönnberg I, Jonason1 T, Nilsson G, Pehrsson K, Ringqvist I. Left ventricular systolic dysfunction in 75-year-old men and women. A population-based study. Eur Heart J 2001 22: 676 683.
21. Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Robbins D, et al. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: The Strong Heart Study. Am Heart J 2001 141: 439 446.
22. Burstein JM, Yan R, Weller I, Abramson BL. Management of congestive heart failure: A gender gap may still exist. Observations from a contemporary cohort. Biomed Central Cardiovasc Disord 2003 3: 1.
23. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domansi M, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. NEJM 2005 352: 225 237.
24. Kadish A, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP, Calkins H, et al. for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. NEJM 2004 350: 2151 2158.
25. Sutton MGST, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, et al. for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003 107: 1985 1990.
26. Sutton MGST, Plappert T, Hilpisch KE, Hayes DL, Chinchoy E, Abraham WT. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative doppler echocardiographic evidence from the multicenter insync randomized clinical evaluation (MIRACLE). Circulation 2006 113: 266 272.
27. Bleeker GB, Schalij MJ, Boersma E, Steendijk P, Van Der Wall EE, Bax JJ. Does a Gender difference in response to cardiac resynchronization therapy exist? Pacing Clin Electrophysiol 2005 28: 1271 1275.
28. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA, Curtis AB. Ventricular reverse remodeling and 6-months outcomes in patients receiving cardiac resynchronization therapy: Analysis of the MIRACLE Study. J Interv Cardiac Electrophysiol 2005 12: 107 113.
29. Yarnoz MJ, Curtis AB. Sex-Based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies effectiveness and use. Card Rev 2006 14: 292 298.
30. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: Effects on the human heart. J Am Coll Cardiol 1995 26: 1068 1079.
31. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992 86: 1099 1107.
32. Kostkiewicz M, Tracz W, Olszowska M, et al. Left ventricular geometry and function in patients with aortic stenosis: Gender differences. Int J Cardiol 1999 71: 57 61.
33. Bella JN, Palmieri V, Wachtell K, et al. Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: The LIFE study. J Hum Hypertension 2004 18: 411 416.
34. Gerdts E, Zabalgoitia M, Bjornstad H, et al. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 2001 87: 980 983.
35. Tamura T, Said S, Gerdes AM. Gender-Related differences in myocyte remodeling in progression to heart failure. Hypertension 1999 33: 676 680.
36. Luchner A, Brockel U, Muscholl M, et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: A population-based study. Cardiovasc Res 2002 53: 720 727.
37. Crebbe DL, Dipla K, Ambati S, et al. Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 2003 41: 300 306.
38. Guerra S, Leri A, Wang X, et al. Myocyte death in the failing human heart is gender dependent. Circ Res 1999 85 856 866.
39. Ghali JK, Piña IL, Gottlieb SS, et al. on Behalf of the MERIT-HF Study Group. Metoprolol CR/XL in female patients with heart failure: Analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002 105: 1585 1591.
40. Adams KF, Sueta CA, Gheorghiade M, et al. for the FIRST Investigators. Gender differences in survival in advanced heart failure: Insights from the FIRST Study. Circulation 1999 99: 1816 1821.